Equity Profile

PAHC

Phibro Animal Health Corporation

Health CarePharmaceuticals$1.3B

Aug26Wed

Pre-Earnings Brief

UpcomingQ4-2026After Close5:00 PM EDT

Company Snapshot

Phibro Animal Health Corporation (PAHC) operates in the health care sector, focusing on pharmaceuticals for animal health. The company plays a crucial role in ensuring the health and productivity of livestock and pets, which is increasingly important as global food demand rises.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors will closely watch this quarter.

$0.80

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and meet demand, crucial for future investments.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

PAHC Q4-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+23.89%

Avg Stock Reaction

+0.37%

Last Quarter Recap

In Q3-2026, Phibro reported an EPS of $0.76, exceeding analyst expectations by 5.85%. The stock reacted positively, gaining 4.02% the following day.

Management Promises & Guidance

Focus on expanding product lines in animal health.
Commitment to improving operational efficiencies.
Plans to enhance customer engagement and support.

Expectations

Wall Street Expectations

Overall, expectations are cautiously optimistic as Phibro has consistently beaten EPS estimates in recent quarters. Investors are looking for continued growth and profitability.

Bull Case

If Phibro maintains its track record of beating EPS estimates, it could signal strong operational performance and market confidence, potentially leading to a significant stock price increase.

Bear Case

However, if the company fails to meet even its own historical performance, it could raise concerns about its growth trajectory and lead to a negative reaction in the stock.

Key Metrics to Watch

Earnings Per Share (EPS)

$0.80

EPS is a key indicator of the company's profitability and financial health, which investors will closely watch this quarter.

Revenue Growth

N/A

Revenue growth reflects the company's ability to expand its market share and meet demand, crucial for future investments.

Gross Margin

N/A

Gross margin indicates how efficiently the company is producing its products, which impacts overall profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the reported EPS for Q4-2026?

Given the company's history of beating EPS estimates, this figure will be crucial in determining market sentiment and stock performance.

How is the company addressing supply chain challenges?

With ongoing global supply chain issues, insights into how Phibro is managing these challenges could impact future growth and profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Phibro's ability to leverage its recent product innovations, which could drive stronger-than-expected revenue growth this quarter.

Supporting Evidence

Phibro has consistently beaten EPS estimates, indicating operational strength.

The options market is pricing a significant move, suggesting traders are anticipating volatility.

Insider selling could indicate confidence in the company's future performance despite short-term fluctuations.

Key Risk

If EPS comes in below $0.70, it could undermine confidence in the company's growth narrative.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it will either reinforce Phibro's growth narrative or raise red flags about its operational challenges.

Bull Confirmed If

An EPS of $0.80 or higher would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $0.70 would confirm the bear case, raising concerns about the company's growth prospects.

Pre-Earnings Positioning

Options Market

Implied Move

±26.15%

Historical Avg

±1.8%

Pricing rich

The options market is pricing in a significant potential move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±22.0% while PAHC has averaged ±1.8% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

100.6%

Calls (100)P/C Ratio: 0.14Puts (600)

Edge

Insider Activity

Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.

Bought

$0.00

0 sh

0 insiders

Sold

$2.4M

42,240 sh

1 insider

Net

$2.4M

Net selling

Most Active Insiders· 12 open-market trades

President and CEOBENDHEIM JACK
$2.4M
Net selling

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Phibro beats expectations, history suggests the stock could rise by around 0.37%, confirming strong operational health.

In-Line / Cautious

If results are in line with expectations, the stock may see muted reactions as investors await further guidance.

Miss

Should the company miss expectations, history suggests a potential decline of around 2.28%, raising concerns about future growth.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Insights into cost management and supply chain strategies.
3Management's outlook on market conditions and competitive landscape.
4Details on customer engagement initiatives and their effectiveness.
5Any changes in guidance or expectations for the next fiscal quarter.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Sandisk Corporation

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors will closely watch this quarter.

$0.80

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and meet demand, crucial for future investments.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

PAHC Q4-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+23.89%

Avg Stock Reaction

+0.37%

Last Quarter Recap

In Q3-2026, Phibro reported an EPS of $0.76, exceeding analyst expectations by 5.85%. The stock reacted positively, gaining 4.02% the following day.

Management Promises & Guidance

Focus on expanding product lines in animal health.
Commitment to improving operational efficiencies.
Plans to enhance customer engagement and support.

Expectations

Wall Street Expectations

Overall, expectations are cautiously optimistic as Phibro has consistently beaten EPS estimates in recent quarters. Investors are looking for continued growth and profitability.

Bull Case

If Phibro maintains its track record of beating EPS estimates, it could signal strong operational performance and market confidence, potentially leading to a significant stock price increase.

Bear Case

However, if the company fails to meet even its own historical performance, it could raise concerns about its growth trajectory and lead to a negative reaction in the stock.

Key Metrics to Watch

Earnings Per Share (EPS)

$0.80

EPS is a key indicator of the company's profitability and financial health, which investors will closely watch this quarter.

Revenue Growth

N/A

Revenue growth reflects the company's ability to expand its market share and meet demand, crucial for future investments.

Gross Margin

N/A

Gross margin indicates how efficiently the company is producing its products, which impacts overall profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the reported EPS for Q4-2026?

Given the company's history of beating EPS estimates, this figure will be crucial in determining market sentiment and stock performance.

How is the company addressing supply chain challenges?

With ongoing global supply chain issues, insights into how Phibro is managing these challenges could impact future growth and profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Phibro's ability to leverage its recent product innovations, which could drive stronger-than-expected revenue growth this quarter.

Supporting Evidence

Phibro has consistently beaten EPS estimates, indicating operational strength.

The options market is pricing a significant move, suggesting traders are anticipating volatility.

Insider selling could indicate confidence in the company's future performance despite short-term fluctuations.

Key Risk

If EPS comes in below $0.70, it could undermine confidence in the company's growth narrative.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it will either reinforce Phibro's growth narrative or raise red flags about its operational challenges.

Bull Confirmed If

An EPS of $0.80 or higher would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $0.70 would confirm the bear case, raising concerns about the company's growth prospects.

Pre-Earnings Positioning

Options Market

Implied Move

±26.15%

Historical Avg

±1.8%

Pricing rich

The options market is pricing in a significant potential move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±22.0% while PAHC has averaged ±1.8% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

100.6%

Calls (100)P/C Ratio: 0.14Puts (600)

Edge

Insider Activity

Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.

Bought

$0.00

0 sh

0 insiders

Sold

$2.4M

42,240 sh

1 insider

Net

$2.4M

Net selling

Most Active Insiders· 12 open-market trades

President and CEOBENDHEIM JACK
$2.4M
Net selling

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Phibro beats expectations, history suggests the stock could rise by around 0.37%, confirming strong operational health.

In-Line / Cautious

If results are in line with expectations, the stock may see muted reactions as investors await further guidance.

Miss

Should the company miss expectations, history suggests a potential decline of around 2.28%, raising concerns about future growth.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Insights into cost management and supply chain strategies.
3Management's outlook on market conditions and competitive landscape.
4Details on customer engagement initiatives and their effectiveness.
5Any changes in guidance or expectations for the next fiscal quarter.